Skip to contentS
SeaStar Medical Holding Corp
S
ICUCWSeaStar Medical Holding Corp Q1 2025 · 10-Q
Revenue$293.00K$293.00K— vs Q1 2024 Net Income-$3.77M-$3.77MN/M vs Q1 2024 EPS Diluted-$0.44-$0.44N/M vs Q1 2024 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SeaStar Medical Holding Corp · CIK 1831868 · Engraved from SEC EDGAR
Operating Cash Flow-$2,654,000N/M Margins · derivedGross margin100.0%
Operating margin-1304.4%
Net margin-1287.4%
ended Mar 31, 2025 · filed May 14, 2025 · 44 d after period end